Arcturus Therapeutics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Arcturus Therapeutics Ltd. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $558.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2019-05-13
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $558.00K.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $255.00K.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $832.00K.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $709.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2019-03-31 | $558.00K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $255.00K 10-K · filed 2019-03-18 |
| 2018-09-30 | $832.00K 6-K · filed 2018-11-07 |
| 2017-12-31 | $709.00K 20-F · filed 2018-05-14 |
| 2015-12-31 | $2.39M 20-F · filed 2016-03-04 |
| 2014-12-31 | $1.16M 20-F · filed 2015-02-27 |
| 2013-12-31 | $5.46M 20-F · filed 2014-03-28 |